OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
Arif Yurdagul, Amanda C. Doran, Bishuang Cai, et al.
Frontiers in Cardiovascular Medicine (2018) Vol. 4
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

The changing landscape of atherosclerosis
Peter Libby
Nature (2021) Vol. 592, Iss. 7855, pp. 524-533
Closed Access | Times Cited: 1691

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Magnus Bäck, Arif Yurdagul, Ira Tabas, et al.
Nature Reviews Cardiology (2019)
Open Access | Times Cited: 1143

Caspases in Cell Death, Inflammation, and Disease
Nina Van Opdenbosch, Mohamed Lamkanfi
Immunity (2019) Vol. 50, Iss. 6, pp. 1352-1364
Open Access | Times Cited: 979

Efferocytosis in health and disease
Amanda C. Doran, Arif Yurdagul, Ira Tabas
Nature reviews. Immunology (2019) Vol. 20, Iss. 4, pp. 254-267
Open Access | Times Cited: 687

Macrophages in Atherosclerosis Regression
Tessa J. Barrett
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 40, Iss. 1, pp. 20-33
Open Access | Times Cited: 497

Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury
Arif Yurdagul, Manikandan Subramanian, Xiaobo Wang, et al.
Cell Metabolism (2020) Vol. 31, Iss. 3, pp. 518-533.e10
Open Access | Times Cited: 354

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
Wei Chen, Maaike Schilperoort, Yihai Cao, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 4, pp. 228-249
Open Access | Times Cited: 344

How macrophages deal with death
Greg Lemke
Nature reviews. Immunology (2019) Vol. 19, Iss. 9, pp. 539-549
Open Access | Times Cited: 338

Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution
Jonathan D. Proto, Amanda C. Doran, Galina A. Gusarova, et al.
Immunity (2018) Vol. 49, Iss. 4, pp. 666-677.e6
Open Access | Times Cited: 335

Inflammation during the life cycle of the atherosclerotic plaque
Peter Libby
Cardiovascular Research (2021)
Open Access | Times Cited: 286

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
Alyssa M. Flores, Niloufar Hosseini-Nassab, Kai-Uwe Jarr, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 2, pp. 154-161
Open Access | Times Cited: 224

Macrophage Death as a Pharmacological Target in Atherosclerosis
Wim Martinet, Isabelle Coornaert, Pauline Puylaert, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 190

Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2019) Vol. 56, pp. 100980-100980
Closed Access | Times Cited: 175

Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
Ira Tabas, Karin Bornfeldt
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1209-1227
Open Access | Times Cited: 172

Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Ping Song, Junqing An, Ming-Hui Zou
Cells (2020) Vol. 9, Iss. 3, pp. 671-671
Open Access | Times Cited: 157

A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus
Viorel Simion, Haoyang Zhou, Stefan Haemmig, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 152

Inflammation Resolution: Implications for Atherosclerosis
Amanda C. Doran
Circulation Research (2022) Vol. 130, Iss. 1, pp. 130-148
Open Access | Times Cited: 104

Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis
Prakash Doddapattar, Rishabh Dev, Madankumar Ghatge, et al.
Circulation Research (2022) Vol. 130, Iss. 9, pp. 1289-1305
Open Access | Times Cited: 82

Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis
Wenli Liu, Nataliya Östberg, Mustafa Yalcınkaya, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 13
Open Access | Times Cited: 71

The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation
Maaike Schilperoort, David Ngai, Santosh R. Sukka, et al.
Immunological Reviews (2023) Vol. 319, Iss. 1, pp. 65-80
Closed Access | Times Cited: 61

PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages
Maaike Schilperoort, David Ngai, Marina Katerelos, et al.
Nature Metabolism (2023) Vol. 5, Iss. 3, pp. 431-444
Closed Access | Times Cited: 59

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59

Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
Guido R.Y. De Meyer, Michelle Zurek, Pauline Puylaert, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 5, pp. 312-325
Closed Access | Times Cited: 58

Inflammasomes and Atherosclerosis: a Mixed Picture
Alan R. Tall, Karin Bornfeldt
Circulation Research (2023) Vol. 132, Iss. 11, pp. 1505-1520
Open Access | Times Cited: 45

Page 1 - Next Page

Scroll to top